Ovarian Cancer: Surgical Considerations
Cytoreductive surgery (CRS) followed by platinum-based chemotherapy is the cornerstone of treatment for advanced epithelial ovarian cancer (EOC). While elderly patients are generally at an increased risk for perioperative morbidity, many studies demonstrate that the elderly are just as likely to benefit from aggressive standard of care treatment as are younger patients. Despite this, elderly patients with cancer are more likely to undergo substandard surgical management, resulting in poorer disease-specific and overall survival. In order to optimize the benefit of CRS while minimizing the risks of perioperative complications, patients must be carefully selected and prepared for surgery. The following chapter presents the current evidence regarding CRS in older patients and reviews important aspects of patient selection, preoperative preparation, intraoperative techniques, postoperative care, and management of complications in older patients with EOC.
KeywordsElderly Ovarian cancer Cytoreductive surgery Perioperative care Postoperative complication
- 1.Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2003 based on November 2005 SEER data submission, posted to the SEER web site, 2006.
- 11.Eisenhauer EL, Tew WP, Levine DA, et al. Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol Oncol. 2007;92(1):27–34.Google Scholar
- 21.Vergote I, Tropé CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer. N Engl J Med. 2010;363(24):2371; author reply 2372.Google Scholar
- 33.Kehoe SM, Eisenhauer EL, Abu-Rustum NR, et al. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. Gynecol Oncol. 1989;112(3):301–6.Google Scholar